Cargando…
Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
Autores principales: | Koumbourlis, Anastassios C., Motoyama, Etsuro K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427374/ https://www.ncbi.nlm.nih.gov/pubmed/32579022 http://dx.doi.org/10.1164/rccm.202004-1471LE |
Ejemplares similares
-
Exogenous surfactant therapy for acute respiratory distress in infancy
por: Moreno, M., et al.
Publicado: (1996) -
The attributable mortality of acute respiratory distress syndrome
por: Auriemma, Catherine L., et al.
Publicado: (2020) -
The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012) -
Surfactant alteration and replacement in acute respiratory distress syndrome
por: Günther, Andreas, et al.
Publicado: (2001) -
Driving Pressure in COVID-19 Acute Respiratory Distress Syndrome Is Associated with Respiratory Distress Duration before Intubation
por: Tsolaki, Vasiliki S., et al.
Publicado: (2021)